Cervomed Stock Performance
| CRVO Stock | 8.98 0.93 11.55% |
CervoMed has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.43, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CervoMed's returns are expected to increase less than the market. However, during the bear market, the loss of holding CervoMed is expected to be smaller as well. CervoMed right now shows a risk of 5.4%. Please confirm CervoMed skewness, as well as the relationship between the day median price and relative strength index , to decide if CervoMed will be following its price patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in CervoMed are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, CervoMed may actually be approaching a critical reversion point that can send shares even higher in August 2025. ...more
Actual Historical Performance (%)
One Day Return 17.89 | Five Day Return 23.25 | Year To Date Return 325.56 | Ten Year Return (99.99) | All Time Return (100.00) |
Last Split Factor 2:3 | Dividend Date 2018-12-14 | Last Split Date 2023-08-17 |
1 | CervoMed Financial Position and Funding Outlook CRVO Stock News | 05/12/2025 |
2 | CervoMed Maintains Buy Rating with Stable Price Target CRVO Stock News | 05/13/2025 |
3 | CervoMed First Quarter 2025 Earnings Beats Expectations | 05/14/2025 |
4 | Acquisition by Boger Joshua S of 5750 shares of CervoMed at 19.01 subject to Rule 16b-3 | 05/29/2025 |
5 | CervoMed Its Rivals Critical Comparison | 06/05/2025 |
6 | CervoMed Receives Continued Buy Rating with Target Price Held Steady CRVO Stock News | 06/11/2025 |
7 | Acquisition by Gregoire Sylvie of 8100 shares of CervoMed at 6.52 subject to Rule 16b-3 | 06/23/2025 |
8 | CervoMed Announces Late-Breaking Presentations at Alzheimers As | 07/08/2025 |
9 | CervoMed Strengthens Leadership with Technical Operations Hire to Advance Neflamapimod Toward Phase 3 | 07/09/2025 |
10 | CervoMed to Present New Data from Phase 2b RewinD-LB Study at AAIC 2025 and Host Conference ... | 07/24/2025 |
| Begin Period Cash Flow | 7.8 M | |
| Total Cashflows From Investing Activities | -28.7 M |
CervoMed Relative Risk vs. Return Landscape
If you would invest 915.00 in CervoMed on April 27, 2025 and sell it today you would lose (17.00) from holding CervoMed or give up 1.86% of portfolio value over 90 days. CervoMed is currently generating 0.111% in daily expected returns and assumes 5.4013% risk (volatility on return distribution) over the 90 days horizon. In different words, 48% of stocks are less volatile than CervoMed, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CervoMed Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CervoMed's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CervoMed, and traders can use it to determine the average amount a CervoMed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0205
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | CRVO | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.4 actual daily | 48 52% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average CervoMed is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CervoMed by adding it to a well-diversified portfolio.
CervoMed Fundamentals Growth
CervoMed Stock prices reflect investors' perceptions of the future prospects and financial health of CervoMed, and CervoMed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CervoMed Stock performance.
| Return On Equity | -0.93 | ||||
| Return On Asset | -0.56 | ||||
| Profit Margin | (2.01) % | ||||
| Operating Margin | (2.77) % | ||||
| Current Valuation | 34.81 M | ||||
| Shares Outstanding | 8.7 M | ||||
| Price To Book | 2.02 X | ||||
| Price To Sales | 7.53 X | ||||
| Revenue | 9.74 M | ||||
| Gross Profit | (11.51 M) | ||||
| EBITDA | (18.23 M) | ||||
| Net Income | (16.29 M) | ||||
| Total Debt | 3.88 M | ||||
| Book Value Per Share | 3.98 X | ||||
| Cash Flow From Operations | (16.53 M) | ||||
| Earnings Per Share | (2.17) X | ||||
| Market Capitalization | 70.06 M | ||||
| Total Asset | 43.08 M | ||||
| Retained Earnings | (70.73 M) | ||||
| Working Capital | 39.2 M | ||||
About CervoMed Performance
By examining CervoMed's fundamental ratios, stakeholders can obtain critical insights into CervoMed's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that CervoMed is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | -1.7 K | -1.6 K | |
| Return On Tangible Assets | (0.38) | (0.40) | |
| Return On Capital Employed | (0.46) | (0.49) | |
| Return On Assets | (0.38) | (0.40) | |
| Return On Equity | (0.42) | (0.44) |
Things to note about CervoMed performance evaluation
Checking the ongoing alerts about CervoMed for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CervoMed help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CervoMed had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 9.74 M. Net Loss for the year was (16.29 M) with loss before overhead, payroll, taxes, and interest of (11.51 M). | |
| CervoMed generates negative cash flow from operations | |
| CervoMed has a poor financial position based on the latest SEC disclosures | |
| About 33.0% of the company shares are held by company insiders | |
| Latest headline from gurufocus.com: CervoMed to Present New Data from Phase 2b RewinD-LB Study at AAIC 2025 and Host Conference ... |
- Analyzing CervoMed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CervoMed's stock is overvalued or undervalued compared to its peers.
- Examining CervoMed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CervoMed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CervoMed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CervoMed's stock. These opinions can provide insight into CervoMed's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CervoMed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in CervoMed Stock, please use our How to Invest in CervoMed guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CervoMed. If investors know CervoMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CervoMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.17) | Revenue Per Share | Quarterly Revenue Growth (0.18) | Return On Assets | Return On Equity |
The market value of CervoMed is measured differently than its book value, which is the value of CervoMed that is recorded on the company's balance sheet. Investors also form their own opinion of CervoMed's value that differs from its market value or its book value, called intrinsic value, which is CervoMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CervoMed's market value can be influenced by many factors that don't directly affect CervoMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CervoMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if CervoMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CervoMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.